RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $168,468,000 | -43.1% | 30,575 | 0.0% | 0.00% | – |
| Q4 2021 | $295,966,000 | -48.7% | 30,575 | -5.3% | 0.00% | – |
| Q3 2021 | $577,488,000 | -41.7% | 32,298 | -20.4% | 0.00% | – |
| Q2 2021 | $990,533,000 | +50.1% | 40,579 | +63.0% | 0.00% | – |
| Q1 2021 | $659,850,000 | +624.5% | 24,900 | +107.5% | 0.00% | – |
| Q4 2020 | $91,080,000 | +51.5% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $60,120,000 | -52.8% | 12,000 | -43.7% | 0.00% | – |
| Q2 2020 | $127,362,000 | +177.9% | 21,298 | +106.8% | 0.00% | – |
| Q1 2020 | $45,835,000 | -53.2% | 10,300 | 0.0% | 0.00% | – |
| Q4 2019 | $97,850,000 | +21.0% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $80,855,000 | -50.1% | 10,300 | 0.0% | 0.00% | – |
| Q2 2019 | $162,019,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |